Onvansertib (NMS-1286937) is a PLK1 inhibitor (IC50=2 nM) with high selectivity and oral activity. Onvansertib has antitumor activity and inhibits tumor growth.
Molecular Weight:
532.52
Purity:
97.01%
CAS Number:
[1034616-18-6]
Formula:
C24H27F3N8O3
Target:
Apoptosis|||PLK
T6247
* VAT and and shipping costs not included. Errors and price changes excepted